Academic interests
- Epidemiology
- Osteoporosis and fractures
- Diabetes
- Social inequalities in health
- Nutrition
Background
- Head, Department of Community Medicine and Global Health, 2018-2021
- Professor in epidemiology
- Postdoctoral research fellow within osteoporosis and fractures
- PhD in epidemiology from Institute of Health and Society (2009), University of Oslo
- University lecturer, Department of Nutrition, University of Oslo
- Clinical Nutritionist, Masters on extracelluar matrix changes in diabetic diabetic nephropathy
Awards
- Young Investigator Award. ASBMR in Minneapolis, Minnesota, October 2012.
- Best poster award. 11th National Osteoporosis Society Conference, Harrogate, England, 2006.
Partners
- Norwegian Epidemiologic Osteoporosis Studies (http://norepos.b.uib.no/)
- Professor Peter Vestergaard, Alborg University, Aalborg, Danmark
- Professor John Eisman and Jacqueline Center, Garvan Institute of Medical Research, Sydney, Australia
Publications
-
Solbakken, Siri Marie; Meyer, Haakon Eduard; Dahl, Cecilie; Finnes, Trine Elisabeth; Hjellvik, Vidar & Nielsen, Christopher Sivert
[Show all 9 contributors for this article]
(2024).
The medication-based Rx-Risk Comorbidity Index and risk of hip fracture - a nationwide NOREPOS cohort study.
BMC Medicine.
ISSN 1741-7015.
22.
doi:
10.1186/s12916-024-03335-w.
Show summary
Background
Few previous studies have assessed overall morbidity at the individual level with respect to future risk of hip fracture. The aim of this register-based cohort study was to examine the association between morbidity measured by the medication-based Rx-Risk Comorbidity Index (Rx-Risk) and the risk of first hip fracture.
Methods
Individual-level data on medications dispensed from pharmacies (2005–2016) was retrieved from the Norwegian Prescription Database and used to calculate Rx-Risk for each calendar year. Information on first hip fractures (2006–2017) was obtained from a nationwide hip fracture database. Individuals ≥ 51 years who filled at least one prescription during the study period comprised the population at risk. Using Rx-Risk as a time-varying exposure variable, relative risk estimates were obtained by a negative binomial model.
Results
During 2006–2017, 94,104 individuals sustained a first hip fracture. A higher Rx-Risk was associated with increased risk of hip fracture within all categories of age and sex. Women with the highest Rx-Risk (> 25) had a relative risk of 6.1 (95% confidence interval (CI): 5.4, 6.8) compared to women with Rx-Risk ≤ 0, whereas the corresponding relative risk in women with Rx-Risk 1–5 was 1.4 (95% CI: 1.3, 1.4). Similar results were found in men. Women > 80 years with Rx-Risk 21–25 had the highest incidence rate (514 (95% CI: 462, 566) per 10, 000 person years). The relative increase in hip fracture risk with higher Rx-Risk was most pronounced in the youngest patients aged 51–65 years.
Conclusions
Rx-Risk is a strong predictor of hip fracture in the general outpatient population and may be useful to identify individuals at risk in a clinical setting and in future studies.
-
-
-
-
Riska, Brit Solvor Lyse; Gunnes, Nina; Stigum, Hein; Finnes, Trine E.; Meyer, Haakon E. & Omsland, Tone K.
[Show all 7 contributors for this article]
(2023).
Time-varying exposure to anti-osteoporosis drugs and risk of first-time hip fracture: a population wide study within the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS).
Osteoporosis International.
ISSN 0937-941X.
34(8),
p. 1369–1379.
doi:
10.1007/s00198-023-06752-4.
Full text in Research Archive
Show summary
We investigated the association between bisphosphonate and denosumab use and risk of hip fracture in Norway. These drugs protect against fractures in clinical trials, but their population-level effect is unknown. Our results showed lowered risk of hip fracture for treated women. Treatment of high-risk individuals could prevent future hip fractures.
Purpose
To investigate whether bisphosphonates and denosumab reduced the risk of first-time hip fracture in Norwegian women when adjusting for a medication-based comorbidity index.
Methods
Norwegian women aged 50–89 in 2005–2016 were included. The Norwegian prescription database (NorPD) supplied data on exposures to bisphosphonates, denosumab, and other drugs for the calculation of the Rx-Risk Comorbidity Index. Information on all hip fractures treated in hospitals in Norway was available. Flexible parametric survival analysis was used with age as time scale and with time-varying exposure to bisphosphonates and denosumab. Individuals were followed until hip fracture or censoring (death, emigration, age 90 years), or 31 December 2016, whichever occurred first. Rx-Risk score was included as a time-varying covariate. Other covariates were marital status, education, and time-varying use of bisphosphonates or denosumab with other indications than osteoporosis.
Results
Of 1,044,661 women 77,755 (7.2%) were ever-exposed to bisphosphonate and 4483 (0.4%) to denosumab. The fully adjusted hazard ratios (HR) were 0.95 (95% confidence interval (CI): 0.91–0.99) for bisphosphonate use and 0.60 (95% CI: 0.47–0.76) for denosumab use. Bisphosphonate treatment gave a significantly reduced risk of hip fracture compared with the population after 3 years and denosumab after 6 months. Fracture risk was lowest in denosumab users who had previously used bisphosphonate: HR 0.42 (95% CI: 0.29–0.61) compared with the unexposed population.
Conclusions
In population-wide real-world data, women exposed to bisphosphonates and denosumab had a lower hip fracture risk than the unexposed population after adjusting for comorbidity. Treatment duration and treatment history impacted fracture risk.
-
Utheim, Mari Nythun; Isaakidis, Petros; Van den Bergh, Rafael; Géraud, Bantas Bata Ghislain; Mabvouna, Rodrigue Biguioh & Omsland, Tone Kristin
[Show all 8 contributors for this article]
(2023).
Provider-initiated HIV testing uptake and socio-economic status among women in a conflict zone in the Central African Republic: a mixed-methods cross-sectional study.
Conflict and Health.
ISSN 1752-1505.
17(1).
doi:
10.1186/s13031-023-00505-0.
-
Dahl, Cecilie; Madsen, Christian; Omsland, Tone Kristin; Søgaard, Anne-Johanne; Tunheim, Ketil & Stigum, Hein
[Show all 8 contributors for this article]
(2022).
The Association of Cold Ambient Temperature With Fracture Risk and Mortality: National Data From Norway - A Norwegian Epidemiologic Osteoporosis Studies (NOREPOS) Study.
Journal of Bone and Mineral Research.
ISSN 0884-0431.
37(8),
p. 1527–1536.
doi:
10.1002/jbmr.4628.
Full text in Research Archive
Show summary
Norway is an elongated country with large variations in climate and duration of winter season. It is also a high-risk country for osteoporotic fractures, in particular hip fractures, which cause high mortality. Although most hip fractures occur indoors, there is a higher incidence of both forearm and hip fractures during wintertime, compared with summertime. In a nationwide longitudinal cohort study, we investigated whether cold ambient (outdoor) temperatures could be an underlying cause of this high incidence and mortality. Hospitalized/outpatient forearm fractures (ICD-10 code S52) and hospitalized hip fractures (ICD-10 codes S72.0-S72.2) from 2008-2018 were retrieved from the Norwegian Patient Registry. Average monthly ambient temperatures (degrees Celsius, °C) from the years 2008-2018 were provided by the Norwegian Meteorological Institute and linked to the residential area of each inhabitant. Poisson models were fitted to estimate the association (Incidence Rate Ratios (IRR), 95% Confidence Intervals (CI)) between temperature and monthly incidence of total number of forearm and hip fractures. Flexible parametric survival models (Hazard ratios (HR), 95% CI) were used to estimate the association between temperature and post hip fracture mortality, taking the population mortality into account. Monthly temperature ranged from -20.2°C to 22.0°C, with a median of -2.0°C in winter and 14.4°C in summer. At low temperatures (
-
Dahl, Cecilie; Holvik, Kristin; Meyer, Haakon E; Stigum, Hein; Solbakken, Siri Marie & Schei, Berit
[Show all 8 contributors for this article]
(2021).
Increased mortality in hip fracture patients living alone: A NOREPOS study.
Journal of Bone and Mineral Research.
ISSN 0884-0431.
36(3),
p. 480–488.
doi:
10.1002/jbmr.4212.
Full text in Research Archive
Show summary
Hip fracture is associated with excess mortality, persisting for many years after the fracture. Several factors may affect survival; however, the role of social support has been less studied. Living situation could be an indicator of a person's social support, which predicts mortality in the general population. In this longitudinal cohort study, we considered whether living alone was a risk factor for post-hip fracture mortality compared with living with a partner. Information on hip fractures from all hospitals in Norway from 2002 to 2013 was combined with the 2001 National Population and Housing Census. The association between living situation and mortality during 12.8 years of follow-up in 12,770 men and 22,067 women aged 50 to 79 years at fracture was investigated using flexible parametric survival analysis. We also estimated relative survival of hip fracture patients compared with that of the non-fractured background population in the same living situation (alone or with a partner). Higher mortality after hip fracture was found in both men and women living alone versus with a partner (hazard ratio [HR] men = 1.37, 95% confidence interval [CI] 1.29—1.44; HR women = 1.23, 95% CI 1.18—1.28, adjusting for age, education level, urbanization degree, and number of children). We demonstrated the strongest association in male hip fracture patients aged <60 years (long-term mortality HR = 3.29, 95% CI 2.25—6.49). Compared with the general population, relative survival 8 years after a hip fracture was 43% in men and 61% in women living alone, whereas relative survival in those living with a partner was 51% in men and 67% in women. In conclusion, hip fracture patients who lived alone had higher mortality than those living with a partner and lower survival relative to the general population.
-
Carlsen, Ellen Øen; Magnus, Maria Christine; Omsland, Tone Kristin; Magnus, Per; Håberg, Siri Eldevik & Wilcox, Allen J.
(2020).
Stumped by the Hump: The Curious Rise and Fall of Norwegian Birthweights, 1991–2007.
Epidemiology.
ISSN 1044-3983.
31(4),
p. 587–594.
doi:
10.1097/EDE.0000000000001211.
-
-
-
-
-
-
-
-
-
-
-
Lopez, Maria Garcia; Baron, John A.; Omsland, Tone Kristin; Søgaard, Anne-Johanne & Meyer, Haakon E
(2018).
Homocysteine‐Lowering Treatment and the Risk of Fracture: Secondary Analysis of a Randomized Controlled Trial and an Updated Meta‐Analysis.
JBMR Plus.
ISSN 2473-4039.
2(5),
p. 295–303.
doi:
10.1002/jbm4.10045.
Full text in Research Archive
-
-
-
-
-
Omsland, Tone Kristin; Eisman, John A.; Næss, Øyvind; Center, Jacqueline R; Gjesdal, Clara Gram & Tell, Grethe Seppola
[Show all 13 contributors for this article]
(2015).
Educational inequalities in post-hip fracture mortality: a NOREPOS studys.
Journal of Bone and Mineral Research.
ISSN 0884-0431.
30(12),
p. 2221–2228.
doi:
10.1002/jbmr.2579.
Show summary
Hip fractures are associated with high excess mortality. Education is an important determinant of health, but little is known about educational inequalities in post-hip fracture mortality. Our objective was to investigate educational inequalities in post-hip fracture mortality and to examine whether comorbidity or family composition could explain any association. We conducted a register-based population study of Norwegians aged 50 years and older from 2002 to 2010. We measured total mortality according to educational attainment in 56,269 hip fracture patients (NORHip) and in the general Norwegian population. Both absolute and relative educational inequalities in mortality in people with and without hip fracture were compared. There was an educational gradient in post-hip fracture mortality in both sexes. Compared with those with primary education only, the age-adjusted relative risk (RR) of mortality in hip fracture patients with tertiary education was 0.82 (95% confidence interval [CI] 0.77-0.87) in men and 0.79 (95% CI 0.75-0.84) in women. Additional adjustments for Charlson comorbidity index, marital status, and number of children did not materially change the estimates. Regardless of educational attainment, the 1-year age-adjusted mortality was three- to fivefold higher in hip fracture patients compared with peers in the general population without fracture. The absolute differences in 1-year mortality according to educational attainment were considerably larger in hip fracture patients than in the population without hip fracture. Absolute educational inequalities in mortality were higher after hip fracture compared with the general population without hip fracture and were not mediated by comorbidity or family composition. Investigation of other possible mediating factors might help to identify new targets for interventions, based on lower educational attainment, to reduce post-hip fracture mortality.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Emaus, Nina; Omsland, TK; Ahmed, Luai; Grimnes, Guri; Sneve, Monica & Berntsen, Gro
(2009).
Bone mineral density at the hip in Norwegian women and men-prevalence of osteoporosis depends on chosen references: the Tromso Study.
European Journal of Epidemiology (EJE).
ISSN 0393-2990.
24(6),
p. 321–328.
doi:
10.1007/s10654-009-9333-z.
-
Omsland, TK; Gjesdal, Clara G; Emaus, Nina; Tell, Grethe S.; Tell, Grethe Seppola & Meyer, Haakon
(2009).
Regional differences in hip bone mineral density levels in Norway: the NOREPOS study.
Osteoporosis International.
ISSN 0937-941X.
20(4),
p. 631–638.
doi:
10.1007/s00198-008-0699-7.
-
Omsland, Tone Kristin; Gjesdal, Clara Gram; Emaus, Nina; Falch, Jan Arvid; Tell, Grethe S & Meyer, HE
(2008).
Regional differences in hip bone mineral density levels in Norway. The NOREPOS Study.
Osteoporosis International.
ISSN 0937-941X.
doi:
10.1007/s00198-008-0699-7.
-
-
Omsland, Tone Kristin; Bangstad, Hans-Jacob; Berg, Tore Julsrud & Kolset, Svein Olav
(2006).
Avanserte glykerte endeprodukter og hyperglykemi.
Tidsskrift for Den norske legeforening.
ISSN 0029-2001.
126(2),
p. 155–158.
-
Gharagzlian, Sedegheh; Borrebæk, Jørgen; Henriksen, Tore; Omsland, Tone Kristin; Shegarfi, Hamid & Kolset, Svein Olav
(2006).
Effect of hyperglycemic condition on proteoglycan secretion in cultured human endothelial cells.
European Journal of Nutrition.
ISSN 1436-6207.
45(7),
p. 369–375.
View all works in Cristin
-
Andreasen, Camilla; Dahl, Cecilie; Frihagen, Frede ; Borgen, Tove Tveitan; Basso, Trude & Gjertsen, Jan-Erik
[Show all 20 contributors for this article]
(2023).
Fracture Liaison Services and Subsequent Fracture Risk: a multicenter, pragmatic, Stepped-Wedge Cluster-Randomized controlled trial.
-
Holvik, Kristin; Dahl, Cecilie; Søgaard, Anne-Johanne; Solbakken, Siri Marie; Tell, Grethe Seppola & Hoff, Mari
[Show all 12 contributors for this article]
(2023).
Educational gradient in hip fracture incidence in Norway. The Norwegian Epidemiologic Osteoporosis Studies (NOREPOS).
Norsk Epidemiologi, Supplement.
ISSN 0803-4206.
31(1),
p. 22–22.
-
Solbakken, Siri Marie; Meyer, Haakon Eduard; Dahl, Cecilie; Finnes, Trine Elisabeth; Hjellvik, Vidar & Nielsen, Christopher Sivert
[Show all 9 contributors for this article]
(2023).
The medication-based Rx-Risk Comorbidity Index and risk of hip fracture. A nationwide NOREPOS cohort study.
Norsk Epidemiologi, Supplement.
ISSN 0803-4206.
31(1),
p. 19–19.
-
Riska, Brit Solvor Lyse; Gunnes, Nina; Stigum, Hein; Finnes, Trine Elisabeth; Meyer, Haakon Eduard & Omsland, Tone Kristin
[Show all 7 contributors for this article]
(2022).
Time-varying exposure to anti-osteoporosis drugs and risk of first-time hip fracture – a population wide study within the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS).
Norsk Epidemiologi, Supplement.
ISSN 0803-4206.
30(1),
p. 19–19.
Show summary
Introduction: Norway has a high hip fracture incidence. Bisphosphonates and denosumab have been shown to prevent hip fractures in clinical trials, but there is a lack of population studies.
Aims: To investigate whether use of bisphosphonates and denosumab reduce the risk of first-time hip fracture in Norway when adjusting for morbidity by the medication-based Rx-Risk Comorbidity index.
Methods: The population was defined as inhabitants identified in the national census of 2001 who were still alive and resident by 1 January 2005. The Norwegian prescription database (NorPD) supplied data on exposures to bisphosphonates, denosumab, and other drugs for the calculation of the Rx-Risk score. Information on previous and incident hip fracture was available in the quality-assured NOREPOS hip fracture database. Persons 50 years or older were included starting from January 2005 and observed through December 2016. Sex-stratified Cox regression and flexible parametric survival analysis was used with age as time scale and with time-varying exposure to bisphosphonates and denosumab. Individuals were followed until hip fracture or censoring (death, emigration, age 90 years, or 31 December 2016, whichever occurred first). Rx-Risk score was included as a time-varying covariate, updated every two years. Other covariates were marital status, education, and time-varying use of bisphosphonates/denosumab with another indication than osteoporosis. Mean time to hip fracture within the observation period (restricted mean survival time) was estimated for the two different treatment exposures.
Results: Of 1,044,661 women and 1,040,782 men, 74,775 (7.2%) and 13,417 (1.3%), respectively, were ever-exposed to either drug. Women exposed to bisphosphonates had a hazard ratio (HR) of 1.09 (95% CI: 1.05–1.13) for hip fracture (age as time-scale), while women exposed to denosumab had an HR of 0.68 (95% CI: 0.53–0.87). The corresponding fully adjusted HRs were 0.95 (95% CI: 0.91–0.99) and 0.58 (95% CI: 0.46–0.74) respectively. Exposure to either of the two drugs gave a longer hip fracture free period in women. For men exposed to either drug, the HRs was well above 1 – also when adjusted.
Conclusions: In population-wide real-world data, women exposed to bisphosphonates had a hip fracture risk around the same level as the unexposed population after adjusting for comorbidity. Exposure to denosumab was associated with a lower risk of hip fracture in women.
-
Riska, Brit Solvor Lyse; Gunnes, Nina; Meyer, Haakon Eduard; Finnes, Trine Elisabeth; Omsland, Tone Kristin & Stigum, Hein
[Show all 7 contributors for this article]
(2022).
Time-varying exposure to anti-osteoporosis drugs and risk of first-time hip fracture – a population wide study within the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS).
-
Riska, Brit Solvor Lyse; Holvik, Kristin; Gunnes, Nina; Omsland, Tone Kristin; Stigum, Hein & Meyer, Haakon Eduard
[Show all 7 contributors for this article]
(2022).
Risk of hip fracture in Norwegians using anti-osteoporosis medication.
Show summary
Introduction: Norway has a high hip fracture incidence. Clinical trials have demonstrated fracture-preventive effects of bisphosphonates (BPs) and denosumab (DMab). We aimed to investigate whether BPs and DMab used in the population of Norway reduce risk of first-time hip fracture when adjusting for morbidity.
Material and methods: Demographic information from participants in the Population and Housing Census 2001 who were alive and resident by 1 January 2005 was linked with filled prescriptions in the Norwegian prescription database (2005-2016) and the NOREPOS hip fracture database. Persons 50 years and older were included starting from January 2005 and observed through December 2016. Sex-stratified time-to-event analysis was used with age as time scale and time-varying exposure to BPs and DMab. The medication-based Rx-Risk Comorbidity Index was added as a time-varying covariate. Other covariates were marital status, education, and exposure to BPs/DMab with another indication than osteoporosis.
Results: Of 1,044,661 women and 1,040,782 men, 74,775 (7.2%) and 13,417 (1.3%), respectively, were ever-users. Age-adjusted hazard ratio (HR) of hip fracture in women was 1.20 (95 % CI: 1.15–1.26) when using BPs, and HR 0.74 (0.55–0.99) when using DMab. Fully adjusted HRs were 1.01 (0.96–1.06) and 0.62 (0.46–0.83) respectively. For men exposed to BPs, HR was well above 1 – also when adjusted.
Conclusions: In population-wide real-world data, women exposed to BPs had a hip fracture risk around the same level as the unexposed population after adjusting for comorbidity. Exposure to DMab was associated with a lower risk of hip fracture in women.
-
Søgaard, Anne-Johanne; Holvik, Kristin; Dahl, Cecilie; Meyer, Haakon Eduard & Omsland, Tone Kristin
(2021).
Osteoporose – den glemte folkesykdom.
Michael.
ISSN 1893-9651.
18(28),
p. 119–133.
Show summary
Osteoporose innebærer at benvevet blir mer porøst og kan brekke ved lav belastning. Svekkelsen i benstrukturen gir ingen symptomer før man får et brudd.
Det er usikkert hvor mange som har osteoporose i Norge, men antallet er beregnet å være nærmere 300 000 personer.
Ofte benyttes osteoporotiske brudd i hofte, underarm og ryggrad som mål på
forekomst av osteoporose som klinisk problem. Hoftebrudd har ofte størst konsekvenser for enkeltindivid og samfunn. Det skjer et hoftebrudd hver time på
døgnet i Norge, totalt ca. 9 000 per år. Kvinner og eldre er mest utsatt.
Norge ligger på verdenstoppen i hoftebrudd, og vi har begrenset kunnskap
om årsakene til dette. Et hoftebrudd koster nesten 1 million kroner det første
året. Selv om hyppigheten har gått ned siden begynnelsen av 1990-årene, vil
antall hoftebrudd likevel øke fremover pga. økende antall eldre. Osteoporose og
fall er de viktigste risikofaktorene, og røyking, lav vekt, lite fysisk aktivitet og
tidligere brudd, virker inn på disse.
Vi omtaler her et pågående prosjekt i Oslo som følger opp fallskader for å
hindre nye fall, og et omfattende prosjekt ved syv sykehus som skal forebygge nye
brudd hos bruddpasienter. Vi spør også hvorfor det tilsynelatende satses så lite
på å forebygge denne folkesykdommen.
-
Dahl, Cecilie; Madsen, Christian; Omsland, Tone Kristin; Søgaard, Anne-Johanne; Holvik, Kristin & Meyer, Haakon E
(2021).
Cold – a risk factor for osteoporotic fractures and fracture related mortality.
Norsk Epidemiologi, Supplement.
ISSN 0803-4206.
29(1),
p. 30–30.
-
-
Aamodt, Geir; Renolen, Ranveig; Omsland, Tone Kristin; Meyer, Haakon E; Rabanal, Kjersti Stormark & Søgaard, Anne-Johanne
(2020).
Ethnic differences in risk of hip fracture in Norway: a NOREPOS study.
Osteoporosis International.
ISSN 0937-941X.
p. 1587–1592.
doi:
10.1007/s00198-020-05390-4.
-
Borgen, Tove Tveitan; Bjørnerem, Åshild; Solberg, Lene Bergendal; Brunborg, Cathrine; Andreasen, Camilla & Hübschle, Lars Michael
[Show all 18 contributors for this article]
(2019).
Individuals with Central Fractures have More Prevalent Vertebral Fractures, Lower Trabecular
Bone Score and Lower BMD than Individuals with Peripheral Fractures: a Sub-study of NoFRACT
.
-
Andreasen, Camilla; G. Rogli, Veronica; Elvenes, Jan; Joakimsen, Ragnar Martin; Borgen, Tove Tveitan & Solberg, Lene Bergendal
[Show all 13 contributors for this article]
(2018).
Tromsoporosis - Secondary Fracture Prevention Program resulted in improved adherence to anti-osteoporotic drugs in Tromsø, Norway.
-
Andreasen, Camilla; G. Rogli, Veronica; Elvenes, Jan; Joakimsen, Ragnar Martin; Borgen, Tove Tveitan & Solberg, Lene Bergendal
[Show all 13 contributors for this article]
(2018).
Tromsoporosis - Secondary Fracture Prevention Program resulted in high adherence to anti-osteoporotic drugs in Tromsø, Norway.
-
Andreasen, Camilla; G. Rogli, Veronica; Elvenes, Jan; Joakimsen, Ragnar Martin; Borgen, Tove Tveitan & Solberg, Lene Bergendal
[Show all 13 contributors for this article]
(2018).
Tromsoporosis - Secondary Fracture Prevention Program resulted in high adherence to anti-osteoporotic drugs in Tromsø, Norway.
-
Solberg, Lene Bergendal; Frihagen, Frede; Basso, Trude; Gjesdal, Clara Gram; Eriksen, Erik Fink & Nordsletten, Lars
[Show all 12 contributors for this article]
(2017).
Updates on the Norwegian Capture the Fracture® Initiative (NoFRACT).
-
Andreasen, Camilla; Osima, Marit; Rognli, Veronica; Grundel, Dag; Elvenes, Jan & Knutsen, Gunnar
[Show all 17 contributors for this article]
(2017).
Tromsoporosis - Adherence to a Secondary Fracture Prevention Program in Tromsø, Norway.
-
-
Holvik, Kristin; Meyer, Haakon E; Laake, Ida; Omsland, Tone Kristin & Søgaard, Anne-Johanne
(2016).
Milk intake in middle-aged Norwegians and risk of hip fracture: Is there an association? A linkage between the Norwegian Counties Study and the NOREPOS hip fracture database.
Food & Nutrition Research (FNR).
ISSN 1654-6628.
60,
p. 31961–31961.
doi:
10.3402/fnr.v60.31961.
-
Holvik, Kristin; Meyer, Haakon E; Laake, Ida; Omsland, Tone Kristin & Søgaard, Anne-Johanne
(2016).
Milk intake in middle-aged Norwegians and risk of hip fracture: Is there an association? A linkage between the Norwegian Counties Study and the NOREPOS hip fracture database.
Norsk Epidemiologi, Supplement.
ISSN 0803-4206.
26,
p. 10–10.
-
Søgaard, Anne-Johanne; Ranhoff, Anette Hylen; Meyer, Haakon E; Omsland, Tone Kristin; Nystad, Wenche & Holvik, Kristin
(2016).
Frequent alcohol consumption increases risk of hip fracture in men below 60 years in Cohort of Norway. A NOREPOS study.
Norsk Epidemiologi, Supplement.
ISSN 0803-4206.
26,
p. 10–10.
-
Lopez, Maria Garcia; Omsland, Tone Kristin; Søgaard, Anne-Johanne & Meyer, Haakon E
(2015).
Increased risk of hip fracture in people with self-perceived memory loss. A NOREPOS based prospective cohort study of 10449 individuals aged 67‐78 years.
European Geriatric Medicine.
ISSN 1878-7649.
6,
p. S11–S11.
-
-
-
Omsland, Tone Kristin
(2014).
Hoftebrudd ingen bagatell.
[Newspaper].
Dagbladet.
-
Dahl, Cecilie; Søgaard, Anne Johanne; Tell, Grethe Seppola; Flaten, Trond Peder; Hongve, Dag & Omsland, Tone Kristin
[Show all 9 contributors for this article]
(2014).
Is copper in drinking water related to risk of hip fracture? And could a possible protective associationbetween calcium and hip fracture be modified by copper?
Norsk Epidemiologi.
ISSN 0803-2491.
24,
p. 48–48.
-
Dahl, Cecilie; Søgaard, Anne Johanne; Tell, Grethe S; Flaten, Trond Peder; Hongve, Dag & Omsland, Tone Kristin
[Show all 10 contributors for this article]
(2013).
Do cadmium and lead in drinking water increase the risk of hip fracture? A NOREPOS study.
-
Omsland, Tone Kristin; Emaus, Nina; Holvik, Kristin; Tell, Grethe S; Ahmed, Luai Awad & Center, Jackie
[Show all 15 contributors for this article]
(2013).
GENDER DIFFERENCES IN ALL-CAUSE MORTALITY FOLLOWING FIRST HIP FRACTURE IN 81,867 NORWEGIAN WOMEN AND MEN: THE NORWEGIAN EPIDEMIOLOGIC OSTEOPOROSIS STUDIES.
Osteoporosis International.
ISSN 0937-941X.
24,
p. S257–S257.
-
Søgaard, Anne-Johanne; Omsland, Tone Kristin & Meyer, Haakon E
(2012).
WHAT ARE THE ASSOCIATIONS BETWEEN WAIST HIP RATIO, BODY MASS INDEX AND HIP FRACTURES? COHORT OF NORWAY.
Osteoporosis International.
ISSN 0937-941X.
23,
p. S526–S526.
-
Dahl, Cecilie; Søgaard, Anne-Johanne; Tell, Grethe S; Flaten, Trond Peder; Hongve, Dag & Omsland, Tone Kristin
[Show all 9 contributors for this article]
(2012).
Do toxic metals in municipal drinking water increase the risk of hip fractures? The NOREPOS study.
-
Omsland, Tone Kristin; Holvik, Kristin; Emaus, Nina; Tell, Grethe S; Schei, Berit & Tverdal, Aage
[Show all 11 contributors for this article]
(2011).
Hip fracture incidence in Norway 1999-2008. Norwegian Epidemiologic Osteoporosis Studies.
Norsk Epidemiologi, Supplement.
ISSN 0803-4206.
21,
p. 38–38.
-
-
-
-
-
Emaus, Nina; Omsland, Tone Kristin; Ahmed, Luai Awad; Grimnes, Guri; Sneve, Markus Handal & Berntsen, Gro
(2009).
BONE MINERAL DENSITY AND PREVALENCE OF OSTEOPOROSIS AT THE HIP IN WOMEN AND MEN AGED 30-85 YEARS - THE TROMSO STUDY.
Osteoporosis International.
ISSN 0937-941X.
20,
p. 64–65.
-
-
Omsland, Tone Kristin; Falch, Jan Arvid; Søgaard, Anne Johanne & Meyer, Haakon E
(2006).
Previous fractures and bone mineral density in elderly men in Oslo.
Osteoporosis International.
ISSN 0937-941X.
17,
p. 382–383.
-
Solbakken, Siri Marie & Omsland, Tone Kristin
(2019).
Hip fracture incidence and mortality: The impact of season, health status and urbanization.
Universitetet i Oslo.
ISSN 978-82-8377-534-1.
View all works in Cristin
Published
Sep. 5, 2014 11:38 AM
- Last modified
Nov. 8, 2021 12:43 PM